Evidence map›Paper›PMID 35656832›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Prevalence and risk factors for hepatitis E virus infection in blood donors: a nationwide survey in Italy, 2017 to 2019.

Enea Spada, Matteo Simeoni, Antonio Martina, Ilaria Pati, Umbertina Villano, Daniela Adriani, Agnese D'Angiò, Elena Tritarelli, Stefania Taffon, Stefania Bellino and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Enea SpadaDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Matteo SimeoniNational Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy.
Antonio MartinaNational Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy.
Ilaria PatiItalian National Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Umbertina VillanoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Daniela AdrianiNational Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy.
Agnese D'AngiòNational Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy.
Elena TritarelliDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stefania TaffonDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stefania BellinoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stefano BorosDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Roberta UrciuoliDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Francesca MasielloItalian National Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Giuseppe MaranoItalian National Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Roberto BruniDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Patrizio PezzottiDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Anna Rita CiccaglioneDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Simonetta PupellaItalian National Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Vincenzo De AngelisItalian National Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Giulio PisaniNational Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy.
Istituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundIn high-income countries, hepatitis E virus (HEV) infection is mainly a zoonosis. However, it is also transfusion-transmissible and some countries, but not Italy, have introduced HEV screening for blood donations.AimWe assessed HEV infection prevalence and risk factors in a nationwide sample of Italian blood donors.MethodsWe selected 107 blood establishments (BE) distributed in the 20 Italian regions by a stratified two-stage design and invited them to participate in the study. Donors were tested for anti-HEV IgG and IgM and HEV RNA. Sociodemographic data and risk factors were collected through a questionnaire.ResultsOverall, 60 BE from 60 provinces in 19 Italian regions joined the study. We assessed HEV markers in 7,172 blood donors, of whom 6,235 completed the questionnaire. Overall crude and adjusted anti-HEV IgG prevalences were 8.3% and 5.5%, respectively. Overall anti-HEV IgM prevalence was 0.5%, while no blood donor was HEV RNA-positive. Anti-HEV IgG prevalence varied widely among regions (range: 1.3%-27.20%) and hyperendemic prevalences (> 40%) were detected in some provinces in two regions. Older age (AOR = 1.81; 95% CI: 1.36-2.41), foreign nationality (AOR = 2.77; 95% CI: 1.06-7.24), eating raw pork liver sausages (AOR = 2.23; 95% CI: 1.55-3.20) and raw homemade sausages (AOR = 3.63; 95% CI: 2.50-5.24) were independent infection predictors.ConclusionItalian blood donors showed a low to moderate HEV seroprevalence. High levels in some regions and/or provinces were mainly attributable to eating habits. Prevention should include avoiding consumption of raw or undercooked meat and safe production of commercial pork products.

Indexed as

Hepatitis EHepatitis E virusBlood DonorsHepatitis AntibodiesHumansImmunoglobulin GImmunoglobulin MPrevalenceRisk FactorsSeroepidemiologic StudiesSurveys and QuestionnairesHepatitis AntibodiesImmunoglobulin GImmunoglobulin Mblood donorHEVItalyprevalencerisk factorzoonosis

Identifiers

PMID35656832
PMCPMC9164674
OpenAlexW4281729862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.